Missing the point, and you’re wrong. RC220 didnt make it obsolete, it was obsolete because the industry doesn’t want it.
IV formula was underway and planned before EMD, RAC were due to expand to 10 sites costing between $7-$15m
Stratum 1 was entirely high dose chemo.
My point still stands. RC220 coming online didn’t invalidate RAC’s strategy, the industry had no commercial interest in high dose chemotherapy and yet they were going to pursue it with up to $15m. And the very 2 people that made these decisions (DT/PL) are still here.
As T said, thank god it didn’t go ahead as it would have wasted a ton of money and probably have been a massive set back, thank god they stuffed it up eh? RC220 arriving makes a better excuse though. At least stratum 2 may have been useful.
That’s all from me
General Comments / Chat, page-9532
-
- There are more pages in this discussion • 1,701 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.37 |
Change
-0.170(11.1%) |
Mkt cap ! $232.5M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.48 | $1.36 | $632.2K | 451.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 76 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 4136 | 2 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |